Scientists test 'Ready-Made' engineered immune cells to fight childhood leukemia
NCT ID NCT05942599
Summary
This early-stage study is testing a new type of cell therapy for children whose acute myeloid leukemia (AML) has returned. Doctors take immune cells from a healthy donor, genetically edit them to target cancer, and infuse them into the patient. The main goal is to see if this 'BE CAR-33' treatment is safe and can help clear the leukemia before the child receives a planned bone marrow transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED ACUTE MYELOID LEUKAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Great Ormond Street Hospital for Children
London, WC1N3JH, United Kingdom
Conditions
Explore the condition pages connected to this study.